Literature DB >> 16096514

Antipsychotic drugs and QT prolongation.

Claudia Stöllberger1, Johannes O Huber, Josef Finsterer.   

Abstract

Antipsychotic drugs (AD) are effective and frequently prescribed to more females than males. AD may cause serious cardiovascular side-effects, including prolonged QT interval, eventually leading to torsades de pointes (TdP) and sudden death. Epidemiologic data and case-control studies indicate an increased rate of sudden death in psychiatric patients taking AD. This review summarizes current knowledge about the QT prolonging effects of AD and gives practical suggestions. Amisulpride, clozapine, flupenthixol, fluphenazine, haloperidol, melperone, olanzapine, perphenazine, pimozide, quetiapine, risperidone, sulpiride, thioridazine and ziprasidone cause a QT prolongation ranging from 4 ms for risperidone to 30 ms for thioridazine. Our knowledge about the QT-prolonging effects of many AD is still limited. Females are under-represented in most studies. Many studies were conducted or supported by pharmaceutical companies. To avoid prodysrhythmia caused by QT prolongation, other factors influencing QT interval have to be considered, such as other drugs affecting the same pathway, hypokalemia, hypomagnesemia, bradycardia, increased age, female sex, congestive heart failure and polymorphisms of genes coding ion channels or enzymes involved in drug metabolism. Because the response of a patient to AD is individual, an electrocardiogram recording the QT interval has to be performed at baseline, after AD introduction and after occurrence of any factor that might influence the QT interval.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16096514     DOI: 10.1097/01.yic.0000166405.49473.70

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  39 in total

1.  Response of i(kr) and HERG currents to the antipsychotics tiapride and sulpiride.

Authors:  Su-Hyun Jo; So-Young Lee
Journal:  Korean J Physiol Pharmacol       Date:  2010-10-31       Impact factor: 2.016

2.  Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States.

Authors:  Charles E Leonard; Cristin P Freeman; Craig W Newcomb; Warren B Bilker; Stephen E Kimmel; Brian L Strom; Sean Hennessy
Journal:  J Clin Exp Cardiolog       Date:  2013

Review 3.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

4.  Cardiac risk and schizophrenia.

Authors:  Ripu Jindal; Erin M MacKenzie; Glen B Baker; Vikram K Yeragani
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

5.  Quetiapine-Induced Bradycardia Without QT Interval Prolongation in an Elderly Woman.

Authors:  André Janse; Radboud M Marijnissen
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

6.  Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice.

Authors:  Megan Beauchemin; Ramaz Geguchadze; Anyonya R Guntur; Kathleen Nevola; Phuong T Le; Deborah Barlow; Megan Rue; Calvin P H Vary; Christine W Lary; Katherine J Motyl; Karen L Houseknecht
Journal:  Pharmacol Res       Date:  2019-12-23       Impact factor: 7.658

Review 7.  The genomics of schizophrenia: update and implications.

Authors:  Paola Giusti-Rodríguez; Patrick F Sullivan
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

Review 8.  Assessing QT interval prolongation and its associated risks with antipsychotics.

Authors:  Jimmi Nielsen; Claus Graff; Jørgen K Kanters; Egon Toft; David Taylor; Jonathan M Meyer
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

9.  All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study.

Authors:  Rosa Liperoti; Graziano Onder; Francesco Landi; Kate L Lapane; Vincent Mor; Roberto Bernabei; Giovanni Gambassi
Journal:  J Clin Psychiatry       Date:  2009-10       Impact factor: 4.384

Review 10.  The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors:  Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.